Study title:
Cancer Treat Rev. 2004 Feb;30(1):83-101.
The value of FDG-PET in the detection, grading and response to therapy of soft
tissue and bone sarcomas; a systematic review and meta-analysis.
Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W,
Hoekstra HJ.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis [E01]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|